Interestingly, ERLIN2 and CDK5RAP3 were correlated with patients’ disease states of complete and partial remission, and this phenomenon implicated that they might influence the outcome of PCa treatment. This evidence concerns the gene CDK5RAP3 and posterior cortical atrophy.